Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS Registry.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS Registry.
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS Registry. Circ Cardiovasc Interv. 2020 04; 13(4):e008226.
View in:
PubMed
subject areas
Age Factors
Age Factors
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Comorbidity
Comorbidity
Coronary Artery Disease
Coronary Artery Disease
Coronary Thrombosis
Coronary Thrombosis
Female
Female
Hemorrhage
Hemorrhage
Humans
Humans
Incidence
Incidence
Male
Male
Medication Adherence
Medication Adherence
Middle Aged
Middle Aged
Percutaneous Coronary Intervention
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Platelet Aggregation Inhibitors
Prevalence
Prevalence
Prospective Studies
Prospective Studies
Registries
Registries
Risk Assessment
Risk Assessment
Risk Factors
Risk Factors
Stents
Stents
Time Factors
Time Factors
Treatment Outcome
Treatment Outcome
authors with profiles
Usman Baber